@article{8c86c1327d634279b14f08f37cf7d0ee,
title = "Adrenal insufficiency in patients taking benralizumab as corticosteroid sparing therapy",
author = "Brian Lipworth and Rasads Misirovs and Rory Chan",
note = "Funding - BL reports non-financial support (equipment) from GSK; grants, personal fees (consulting, talks, and advisory board), and other support (attending American Thoracic Society and European Respiratory Society [ERS]) from AstraZeneca; grants, personal fees (consulting, talks, advisory board), and other support (attending ERS) from Teva; personal fees (consulting, talks and advisory board) from Circassia in relation to the submitted work; personal fees (consulting) from Sanofi, Lupin, Glenmark, Vectura, Dr Reddy, and Sandoz; grants, personal fees (consulting, talks, advisory board), other support (attending British Thoracic Society) from Boehringer Ingelheim; grants and personal fees (advisory board and talks) from Mylan outside of the submitted work. BL{\textquoteright}s son is an employee of AstraZeneca. RM and RC declare no competing interests",
year = "2022",
month = jan,
day = "1",
doi = "10.1016/S2213-2600(21)00487-2",
language = "English",
volume = "10",
pages = "e7",
journal = "The Lancet Respiratory Medicine",
issn = "2213-2600",
publisher = "Elsevier",
number = "1",
}